- Home
- PPTA vs TVTX Comparison
PPTA vs TVTX Comparison
Compare PPTA & TVTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PPTA | TVTX |
|---|---|---|
| Founded | 2011 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 3.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | PPTA | TVTX |
|---|---|---|
| Price | $25.66 | $34.98 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 15 |
| Target Price | $25.38 | ★ $37.21 |
| AVG Volume (30 Days) | ★ 2.6M | 1.6M |
| Earning Date | 11-17-2025 | 10-30-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $435,826,000.00 |
| Revenue This Year | N/A | $120.36 |
| Revenue Next Year | N/A | $37.33 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 114.22 |
| 52 Week Low | $7.81 | $12.91 |
| 52 Week High | $31.65 | $37.50 |
Technical Indicators
Market Signals| Indicator | PPTA | TVTX |
|---|---|---|
| Relative Strength Index (RSI) | 58.94 | 56.76 |
| Support Level | $24.26 | $33.45 |
| Resistance Level | $26.68 | $35.64 |
| Average True Range (ATR) | 1.54 | 1.51 |
| MACD | 0.24 | -0.40 |
| Stochastic Oscillator | 81.27 | 39.01 |
Price Performance
Historical ComparisonAbout PPTA Perpetua Resources Corp.
Perpetua Resources Corp is focused on the exploration, site restoration, and redevelopment of gold-antimony-silver deposits in the Stibnite-Yellow Pine district of central Idaho that are encompassed by the Stibnite Gold Project. The Project is one of the highest-grade, open-pit gold deposits in the United States and is designed to apply a modern, responsible mining approach to restore an abandoned mine site and produce both gold and the only mined source of antimony in the United States. It has one segment, mineral exploration in the United States.
About TVTX Travere Therapeutics Inc.
Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.